[1]乔喜婷,邱春丽△,肖海娟,等.益气通腑汤预防结直肠癌根治术后复发转移疗效研究*[J].陕西中医,2019,(11):1513-1515.
　QIAO Xiting,QIU Chunli,XIAO Haijuan,et al.Yiqi Tongfu decoction on the prevention of recurrence and metastasis after radical resection of colorectal cancer[J].,2019,(11):1513-1515.
点击复制

益气通腑汤预防结直肠癌根治术后复发转移疗效研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年11期
页码:
1513-1515
栏目:
临床研究
出版日期:
2019-11-05

文章信息/Info

Title:
Yiqi Tongfu decoction on the prevention of recurrence and metastasis after radical resection of colorectal cancer
文章编号:
DOI:10.3969/j.issn.10007369.2019.11.007
作者:
乔喜婷1; 邱春丽1△; 肖海娟2; 代引海3; 杨林1; 方瑜4
1.陕西省咸阳市中心医院（咸阳 712000）；2.陕西中医药大学附属医院（咸阳 712000）；3.陕西中医药大学第二附属医院（咸阳 712000）；4.陕西中医药大学基础医学院（咸阳 712000）
Author(s):
QIAO Xiting; QIU Chunli; XIAO Haijuan; et al.
Xianyang Central Hospital in Shaanxi Province(Xianyang 712000)
关键词:
结直肠癌根治术; 益气通腑汤; 复发转移; 血清肿瘤标志物癌胚抗原; 糖类抗原199; 疗效研究
Keywords:
Key words Radical resection of colorectal cancer; Yiqi Tongfu decoction; Recurrence and metastasis; CEA; CA199; Therapeutic effect study
分类号:
R735.37
文献标志码:
A
摘要:
摘要目的：研究益气通腑汤在预防结直肠癌根治术后复发转移的临床疗效。方法：将124例结直肠癌根治术患者随机分为治疗组和对照组各62例，两组均于根治术后予以常规西医治疗，治疗组加用益气通腑汤治疗。观察两组患者术后第1年、第2年、第3年复发转移率，比较两组患者术前、术后1年血清肿瘤标志物癌胚抗原（CEA）、糖类抗原199（CA199）含量和复发转移相关蛋白血管内皮生长因子（VEGF）、基质金属蛋白酶9（MMP9）、骨桥蛋白（OPN）含量变化，并记录两组患者化疗不良反应发生率。结果：术后第2年，治疗组和对照组各失访1例，术后3年，治疗组失访5例、对照组失访3例。术后第2年、第3年及总复发转移率治疗组均低于对照组（P＜005）；术后1年，两组CEA、CA199均低于术后即刻（P＜005），治疗组降低幅度明显优于对照组（P＜005）；术后1年，两组患者VEGF、MMP9、OPN水平均低于术后即刻（P＜005），治疗组降幅大于对照组（P＜005）；两组血小板减少、红细胞减少、肝功能损害发生率比较，差异无统计学意义（P＞005）；治疗组白细胞减少、恶心呕吐、胃肠道反应发生率均低于对照组（P＜005）。结论：益气通腑汤有利于预防结直肠癌根治术后复发转移，降低CEA、CA199血清肿瘤标志物含量和VEGF、MMP9、OPN复发转移相关蛋白含量，减轻化疗毒副反应，提高临床疗效。
Abstract:
AbstractObjective:To study the clinical effect of Yiqi Tongfu decoction in preventing recurrence and metastasis of colorectal cancer after radical operation.Methods:124 patients with radical resection of colorectal cancer were randomly divided into treatment group and control group,62 cases in each group.Both groups were treated with routine western medicine after radical resection.The treatment group was treated with Yiqi Tongfu decoction.The recurrence and metastasis rates in the first,second and third year after operation were observed.The serum levels of carcinoembryonic antigen (CEA),carbohydrate antigen 199 (CA199),vascular endothelial growth factor (VEGF),matrix metalloproteinase9 (MMP9) and osteopontin content were compared between the two groups before and after operation.The incidence of adverse reactions to chemotherapy in the two groups were recorded.Results:In the second year after operation,1 case in the treatment group and 1 case in the control group was lost.5 cases in the treatment group and 3 cases in the control group was lost in the third year after operation.The recurrence and metastasis rates in the treatment group were lower than those in the control group (P＜005).After operation 1 year,in CEA and CA199 both groups were lower than that immediately after operation (P＜005),and the treatment group was significantly better than that in the control group (P＜005).After operation 1 year,the levels of vascular endothelial growth factor,MMP9 and OPN in both groups were lower than that immediately after operation (P＜005).The decrease of the treatment group was greater than that of the control group (P＜005);there was no significant difference in the incidence of thrombocytopenia,erythrocytopenia and liver function damage between the two groups 〖LM〗 (P＞005);the incidence of leucopenia,nausea and vomiting,gastrointestinal reaction in the treatment group waslower than that in the control group (P＜005).Conclusions:Yiqi Tongfu decoction can prevent recurrence and metastasis of colorectal cancer after radical operation,reduce the contents of serum tumor markers CEA,CA199 and related proteins of VEGF,MMP9 and OPN,reduce the toxicity and side effects of chemotherapy,and improve the clinical efficacy.

参考文献/References:

[1]刘建军,魏寿江.结肠癌术后肿瘤复发转移的影响因素及远期预后观察[J].中国现代普通外科进展,2017,20(1):6970.
[2]马瑞,徐玲,曲秀娟,等.结直肠癌的中药治疗进展[J].辽宁中医杂志,2017,44(10):22172219.
[3]瑞胜,覃露,吴泽铃,等.扶阳思想在结直肠癌根治术后应用探讨[J].北京中医药,2017,36(8):730731.
[4]郭凯波,严卿莹,阮善明,等.中医药联合化疗预防Ⅱ~Ⅲ期结直肠癌术后复发转移的Meta分析[J].广州中医药大学学报,2017,34(4):617622.
[5]卢冬雪,刘沈林.中医药防治结直肠癌术后复发转移的概况[J].世界中西医结合杂志,2017,12(11):16201623.
[6]侯风刚,石齐,刘宣,等.辨证、辨病治疗在中药预防结直肠癌术后复发转移中的作用[J].中华中医药杂志,2016,31(6):21542160.
[7]曹文，周小青.艾迪注射液协同化疗对结直肠癌肝转移患者肿瘤标志物CEA、CA199的影响[J].中医药导报,2019,25(4):7072.
[8]杜瑀煊,柴可群,陈嘉斌,等.治疗结直肠癌复发转移的中药用药规律分析[J].肿瘤学杂志,2017,23(2):97100.
[9]莫淑婵,田甜,吴钟彪.益气清化汤灌肠对脾虚湿热型结直肠癌术后化疗患者副反应及血清IGF1、EGF的影响[J].中医药导报,2017,23(22):4951.
[10]王倩竹,江伟廷,李恒,等.健脾抑癌汤防治结直肠癌术后复发及癌转移的效果及作用分析[J].四川中医,2017,35(3):8082.
[11]赵仑.益气通腑汤对直肠癌根治术患者术后肠壁通透性及VEGF表达的影响[J].中医学报,2017,32(8):13551359.
[12]申妮,张永利,王志尚,等.新辅助化疗对直肠癌患者肿瘤标志物与疾病复发转移指标的影响[J].实用癌症杂志,2018,33(1):9698.
[13]樊长征,洪巧瑜.党参对人体各系统作用的现代药理研究进展[J].中国医药导报,2016,13(10):3943.
[14]毛景欣.川木香化学成分及药理作用研究进展[J].中草药,2017,48(22):47974803.
[15]邢梦雨,田崇梅,夏道宗.乌药化学成分及药理作用研究进展[J].天然产物研究与开发,2017,29(12):21472151.

备注/Memo

备注/Memo:
*陕西省自然科学基金资助项目（2015JQ8288）
更新日期/Last Update: 2019-11-15